Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study

M. Wang; J. C-H. Yang; P. Mitchell; J. Fang; W. Nian; C. H. Chiu; J. Zhou; Y. Zhao; W-C. Su; D. R. Camidge; T-Y. Yang; V. Zhu; M. Millward; Y. Fan; Y. Cheng; L. Jiang; L. Zheng; P. A. Jaenne

doi:10.1016/j.annonc.2022.07.1114

Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study

M. Wang, J. C-H. Yang, P. Mitchell, J. Fang, W. Nian, C. H. Chiu, J. Zhou, Y. Zhao, W-C. Su, D. R. Camidge, T-Y. Yang, V. Zhu, M. Millward, Y. Fan, Y. Cheng, L. Jiang, L. Zheng, P. A. Jaenne

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	S1003-S1004
Number of pages	2
Journal	Annals of Oncology
Volume	33
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.1114
Publication status	Published - Sept 2022
Event	Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) - Duration: 9 Sept 2022 → 13 Sept 2022

Access to Document

10.1016/j.annonc.2022.07.1114

Cite this

Wang, M., Yang, J. C.-H., Mitchell, P., Fang, J., Nian, W., Chiu, C. H., Zhou, J., Zhao, Y., Su, W.-C., Camidge, D. R., Yang, T.-Y., Zhu, V., Millward, M., Fan, Y., Cheng, Y., Jiang, L., Zheng, L., & Jaenne, P. A. (2022). Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study. Annals of Oncology, 33(7), S1003-S1004. https://doi.org/10.1016/j.annonc.2022.07.1114

@article{b0216aa83b244dabaf7b8fcf3281aaf4,

title = "Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study",

author = "M. Wang and Yang, {J. C-H.} and P. Mitchell and J. Fang and W. Nian and Chiu, {C. H.} and J. Zhou and Y. Zhao and W-C. Su and Camidge, {D. R.} and T-Y. Yang and V. Zhu and M. Millward and Y. Fan and Y. Cheng and L. Jiang and L. Zheng and Jaenne, {P. A.}",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1114",

language = "English",

volume = "33",

pages = "S1003--S1004",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

note = "Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ESMO ; Conference date: 09-09-2022 Through 13-09-2022",

}

Wang, M, Yang, JC-H, Mitchell, P, Fang, J, Nian, W, Chiu, CH, Zhou, J, Zhao, Y, Su, W-C, Camidge, DR, Yang, T-Y, Zhu, V, Millward, M, Fan, Y, Cheng, Y, Jiang, L, Zheng, L & Jaenne, PA 2022, 'Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study', Annals of Oncology, vol. 33, no. 7, pp. S1003-S1004. https://doi.org/10.1016/j.annonc.2022.07.1114

TY - JOUR

T1 - Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations

T2 - Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)

AU - Wang, M.

AU - Yang, J. C-H.

AU - Mitchell, P.

AU - Fang, J.

AU - Nian, W.

AU - Chiu, C. H.

AU - Zhou, J.

AU - Zhao, Y.

AU - Su, W-C.

AU - Camidge, D. R.

AU - Yang, T-Y.

AU - Zhu, V.

AU - Millward, M.

AU - Fan, Y.

AU - Cheng, Y.

AU - Jiang, L.

AU - Zheng, L.

AU - Jaenne, P. A.

PY - 2022/9

Y1 - 2022/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000866211601254&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1016/j.annonc.2022.07.1114

DO - 10.1016/j.annonc.2022.07.1114

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 33

SP - S1003-S1004

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

Y2 - 9 September 2022 through 13 September 2022

ER -

Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study

Access to Document

Other files and links

Cite this